---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-074231"
form_type: "8-K"
ticker: "AGEN"
cik: "0001098972"
company_name: "AGENUS INC"
filed_at: "2024-06-17T23:59:59+00:00"
generated_at: "2026-06-01T04:02:40.421515+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Agenus appoints Jennifer Buell to Board of Directors, stresses BOT/BAL BLA filing

## Summary
- Dr. Jennifer Buell appointed to Agenus Board effective June 11, 2024.
- Buell remains President/CEO of MiNK Therapeutics and Chairman of Agenus Executive Council.
- Priority is to guide BOT/BAL program toward Biologics License Application submission this year.
- Brings 27+ years biopharma experience; previously served as President & COO of Agenus.
- No committee assignments; previously granted options for 37,500 shares (2023 and 2024).

## SEC filing metadata
- accession: 0000950170-24-074231
- form_type: 8-K
- ticker: AGEN
- cik: 0001098972
- company_name: AGENUS INC
- filed_at: 2024-06-17T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1098972/000095017024074231/0000950170-24-074231-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1098972/000095017024074231/agen-20240611.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-074231
- JSON: https://secwatch.observer/filing/0000950170-24-074231.json
- Plain text: https://secwatch.observer/filing/0000950170-24-074231.txt

## Key facts
- Executive change
  Jennifer Buell was appointed as Director at AGENUS INC.
  - Action: appointed
  - Role: Director
  source text: Dr. Jennifer Buell was appointed to the Board of Directors of Agenus Inc. (Agenus) on June 11, 2024, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1098972/000095017024074231/0000950170-24-074231-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.